CDK2-IN-13
Product Specifications
UNSPSC Description
CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with an IC50 of 12 µM. CDK2-IN-13 can be used in research of cancer[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-13.html
Purity
98.20
Solubility
DMSO : 11.11 mg/mL (ultrasonic;warming;adjust pH to 11 with NaOH;heat to 60°C)
Smiles
CN1C=NC2=C(N=C(N=C21)Cl)NCC3=CC=CC=C3
Molecular Weight
273.727
References & Citations
[1]Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40(4):408-12.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W478102/CDK2-IN-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W478102/CDK2-IN-13-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
101622-53-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
